total crap. B&L is alive, well and healthy and growing. allergan has no clue in eye care they dont even have surgical they spun it off, what do they know
Who is you and who is we Allergan dominates eyecare and knows everything about this space, including but not limited to IMS data containing B&L products. B&L retroactively lowers 2013 numbers to make 2014 growth look better and takes 20+% price increases on amazing products like Besivance.
view from europe - allergan is resorting to "the offer is grossly undervalued". they seem to have given up attacking B&L performance.
Exactly. The industry knows B&L has some decent products, but their sales and marketing idiots don't know how to sell it. B&L's numbers might appear healthy on the surface, but a dig deeper reveals it's merely due to expectation manipulation and margin increases over last year. It most certainly is not because of volume increases (if in doubt, have a conversation with the directors and managers at the plant level - production is flat from last year to this year). Visit the marketing "brain trust" in California, and you'll quickly discover how incompetent they are.